We are looking for exclusive regional or local licensing and distribution rights for ethical pharmaceutical (Rx and OTC) and consumer health products in areas with a high, yet unmet need. We are interested in ready-to-market, finished products or innovative drug candidates in late-stage clinical development (clinical phase 3 for standard pharmaceuticals; phase 2 proof-of-concept for orphan drugs).
Our key therapeutic areas of interest are gastroenterology, neurology (CNS), oncology including haematology, immunology and in particular inflammatory, autoimmune and respiratory disorders, and infectious diseases. QuadroPharma also covers treatments for internal medicine, paediatrics, gynaecology, hepatology, nephrology, dermatology, endocrinology, cardiology and radiology.
If your licensing opportunity lies outside of our core focus areas, we are still interested in hearing about it. We have an opportunistic approach and are open to evaluating any asset that could be promising for our current or future product portfolio.